Remedy Entertainment Plc Stock exchange release September 22, 2026 at 9.30 a.m. EEST
The Board of Directors of Remedy Entertainment Plc has, by virtue of the authorization granted by the Annual General Meeting held on May 21, 2026, decided to adopt an option plan “Option Plan 2026” directed to the key people as decided separately by the Board of Directors. There is a weighty financial reason to issue the option rights as the option plan is a part of the company’s incentive and commitment scheme for its key people.
The maximum total number of option rights issued is 350,000, entitling their holders to subscribe for a maximum of 350,000 new shares of the company or existing shares held by the company. The option rights will be granted without payment. The Board of Directors may allocate option rights until the beginning of the share subscription period. The share subscription period will begin on June 1, 2029, and end on May 31, 2032.
The subscription price for a share subscribed for with one option right is EUR 16.29, which is the trade volume weighted average price of the Company’s share on the official list of Nasdaq Helsinki Ltd during June 1–August 31, 2026, with an addition of 10 percent.
The number of outstanding shares may increase at maximum by 350,000 shares as a result of the share subscriptions with the option rights, equaling 2.57 percent of all shares and votes in the company after the possible share subscription, if only new shares are issued in the subscription. In addition, the company has 270,000 unexercised option rights under the Option Plan 2021, 292,000 unexercised option rights under the Option Plan 2022, and 306,000 unexercised option rights under the Option Plan 2023. For Option Plans 2024 and 2025, the maximum number of options that can be issued is 350,000 options per plan.
The theoretical market value of one option under the new plan is approximately EUR 9.12, whereas the theoretical market value of all options from plan 2026 is approximately EUR 3,191,000. The theoretical market value of one option has been calculated based on the closing price on 21 September 2026, and by applying the Black-Scholes model used for pricing options with the following criteria: share price EUR 18.34, strike price EUR 16.29, risk-free interest rate 3.77 %, validity period of the option rights 5.7 years, and volatility 43%.
The terms and conditions of Option Plan 2026 are attached to this release and will be available on the company’s website at https://investors.remedygames.com/en/corporate_governance/remuneration.
REMEDY ENTERTAINMENT PLC
More Information
Ieva Kovarskyte, Legal Director
Phone: +358 40 726 5399
Email: ieva.kovarskyte@remedygames.com
Remedy in brief
Remedy Entertainment Plc is a pioneering, globally renowned video game company founded in 1995 and headquartered in Finland with an office in Stockholm, Sweden. Known for its story-driven and visually stunning action games, Remedy has created multiple successful, critically acclaimed franchises such as Control, Alan Wake, and Max Payne. Remedy also develops its own Northlight game engine and tools technology that powers its games. Remedy’s shares are listed on Nasdaq Helsinki’s main list.